Fig 2. Patient 2. Erythematous rectangular patch localized to the vaccination site. To the Editor: We read with great interest the case series by Sidlow et al describing the urticarial… Click to show full abstract
Fig 2. Patient 2. Erythematous rectangular patch localized to the vaccination site. To the Editor: We read with great interest the case series by Sidlow et al describing the urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination. With mass vaccination unfolding, it is imperative that providers and patients are aware of this benign reaction to receive proper treatment and reassurance. We report 4 cases of cutaneous hypersensitivity reactions following Moderna messenger RNA (mRNA)-1273 vaccination that presented to a small community practice.
               
Click one of the above tabs to view related content.